Session

Overview: In this session, we will comprehensively discuss the subject of hypofractionation in cancer treatment. Prof. Martin Pruschy will delve into recent biological insights, emphasizing hypoxia, immune responses, and the potential for combined treatments. Prof. Paul Keall will discuss the technological impacts on treatment accuracy and upcoming trends in adaptive radiation therapy. Dr. Yolanda Prezado will introduce novel technologies and techniques for hypofractionation delivery, and their suitability for particular tumours. Finally, dr. Evert Van Limbergen will present clinical evidence and ongoing trials in hypofractionation for major cancer types, highlighting the significance of landmark trials, and clinically challenging aspects of radiosensitivity.